259 related articles for article (PubMed ID: 11160611)
1. Effective plasma concentration of a novel Na+/Ca2+ channel blocker NS-7 for its cerebroprotective actions in rats with a transient middle cerebral artery occlusion.
Aoki Y; Tamura M; Itoh Y; Seto T; Nonaka K; Mukai H; Ukai Y
J Pharmacol Exp Ther; 2001 Feb; 296(2):306-11. PubMed ID: 11160611
[TBL] [Abstract][Full Text] [Related]
2. Cerebroprotective action of a Na+/Ca2+ channel blocker NS-7. I. Effect on the cerebral infarction and edema at the acute stage of permanent middle cerebral artery occlusion in rats.
Aoki Y; Tamura M; Itoh Y; Ukai Y
Brain Res; 2001 Jan; 890(1):162-9. PubMed ID: 11164779
[TBL] [Abstract][Full Text] [Related]
3. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.
Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234
[TBL] [Abstract][Full Text] [Related]
4. Preferential inhibition by a novel Na(+)/Ca(2+) channel blocker NS-7 of severe to mild hypoxic injury in rat cerebrocortical slices: A possible involvement of a highly voltage-dependent blockade of Ca(2+) channel.
Oka M; Itoh Y; Ukai Y
J Pharmacol Exp Ther; 2000 May; 293(2):522-9. PubMed ID: 10773024
[TBL] [Abstract][Full Text] [Related]
5. Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats.
Campbell CA; Mackay KB; Patel S; King PD; Stretton JL; Hadingham SJ; Hamilton TC
Exp Neurol; 1997 Nov; 148(1):45-50. PubMed ID: 9398449
[TBL] [Abstract][Full Text] [Related]
6. Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats.
Lukic-Panin V; Kamiya T; Zhang H; Hayashi T; Tsuchiya A; Sehara Y; Deguchi K; Yamashita T; Abe K
Brain Res; 2007 Oct; 1176():143-50. PubMed ID: 17904110
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats.
Thiyagarajan M; Kaul CL; Sharma SS
Br J Pharmacol; 2004 Jul; 142(5):899-911. PubMed ID: 15197101
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of the novel cerebrovascular-selective calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate on ischemic brain damage after permanent middle cerebral artery occlusion in rats.
Minato H; Honda Y; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1996 Jun; 46(6):567-71. PubMed ID: 8767345
[TBL] [Abstract][Full Text] [Related]
9. Cerebroprotective action of a Na+/Ca2+ channel blocker NS-7. II. Effect on the cerebral infarction, behavioral and cognitive impairments at the chronic stage of permanent middle cerebral artery occlusion in rats.
Tamura M; Aoki Y; Seto T; Itoh Y; Ukai Y
Brain Res; 2001 Jan; 890(1):170-6. PubMed ID: 11164780
[TBL] [Abstract][Full Text] [Related]
10. Permeability of a neuroprotective compound NS-7 into brain: comparison between normal and middle cerebral artery-occluded rats.
Itoh Y; Aoki Y; Nonaka K; Ukai Y; Yoshikuni Y; Kimura K
Life Sci; 1997; 61(10):957-66. PubMed ID: 9296334
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of taurine against focal cerebral ischemia in rats possibly mediated by activation of both GABAA and glycine receptors.
Wang GH; Jiang ZL; Fan XJ; Zhang L; Li X; Ke KF
Neuropharmacology; 2007 Apr; 52(5):1199-209. PubMed ID: 17386936
[TBL] [Abstract][Full Text] [Related]
12. Mild hypothermia enhances the neuroprotective effects of FK506 and expands its therapeutic window following transient focal ischemia in rats.
Nito C; Kamiya T; Ueda M; Arii T; Katayama Y
Brain Res; 2004 May; 1008(2):179-85. PubMed ID: 15145754
[TBL] [Abstract][Full Text] [Related]
13. Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume.
Harrigan MR; Ennis SR; Sullivan SE; Keep RF
Acta Neurochir (Wien); 2003 Jan; 145(1):49-53. PubMed ID: 12545262
[TBL] [Abstract][Full Text] [Related]
14. The mitochondrial K(ATP) channel opener BMS-191095 reduces neuronal damage after transient focal cerebral ischemia in rats.
Mayanagi K; Gáspár T; Katakam PV; Kis B; Busija DW
J Cereb Blood Flow Metab; 2007 Feb; 27(2):348-55. PubMed ID: 16736040
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion.
Graham SH; Chen J; Lan J; Leach MJ; Simon RP
J Pharmacol Exp Ther; 1994 May; 269(2):854-9. PubMed ID: 7910213
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of the new pyrimidine derivative NS-7, a novel Na+/Ca2+ channel blocker. 1st communication: plasma concentrations and excretions after a single intravenous 14C-NS-7 injection to rats, dogs and monkeys.
Nonaka K; Tsujioka T; Tougou K; Mukai H
Arzneimittelforschung; 2003; 53(9):612-20. PubMed ID: 14558434
[TBL] [Abstract][Full Text] [Related]
17. Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.
Sydserff SG; Borelli AR; Green AR; Cross AJ
Br J Pharmacol; 2002 Jan; 135(1):103-12. PubMed ID: 11786485
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of albumin on VEGF and brain edema in acute ischemia in rats.
Yao X; Miao W; Li M; Wang M; Ma J; Wang Y; Miao L; Feng H
Neurosci Lett; 2010 Mar; 472(3):179-83. PubMed ID: 20138968
[TBL] [Abstract][Full Text] [Related]
19. Reperfusion-induced temporary appearance of therapeutic window in penumbra after 2 h of photothrombotic middle cerebral artery occlusion in rats.
Yao H; Yoshii N; Akira T; Nakahara T
J Cereb Blood Flow Metab; 2009 Mar; 29(3):565-74. PubMed ID: 19088742
[TBL] [Abstract][Full Text] [Related]
20. Gene transfer of PEDF attenuates ischemic brain damage in the rat middle cerebral artery occlusion model.
Sanagi T; Yabe T; Yamada H
J Neurochem; 2008 Aug; 106(4):1841-54. PubMed ID: 18624913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
